Clinical evaluation of 1,3-bis(2-chloroethyl)-nitrosourea (BCNU; NSC-409962) with fluoxymesterone (NSC-12165) in the treatment of solid tumors.
D001943:Breast Neoplasms / Q000188:drug therapy; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D002330:Carmustine / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004487:Edema / Q000139:chemically induced; D005474:Fluoxymesterone / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000097:blood / Q000188:drug therapy*; D010689:Phlebitis / Q000139:chemically induced; D012004:Rectal Neoplasms / Q000188:drug therapy; D013997:Time Factors
D005474:Fluoxymesterone; D002330:Carmustine